|

Predicting Adverse Outcomes Using Machine Learning of COPD Patients in Hong Kong

RECRUITINGSponsored by Chinese University of Hong Kong
Actively Recruiting
SponsorChinese University of Hong Kong
Started2023-08-29
Est. completion2026-04-30
Eligibility
Age40 Years+
Healthy vol.Accepted

Summary

This study aims to develop predictive models for patients with a diagnosis of COPD at discharge of an index admission on these outcomes using machine learning: Primary outcome: Early admission Secondary outcomes: 1. Frequent readmission 2. Composite outcome (Early + Frequent readmissions) 3. Mortality 4. Longstayers

Eligibility

Age: 40 Years+Healthy volunteers accepted
Inclusion Criteria:

* ≥40 years
* Patients are discharged from 2016 -2022
* Discharge Diagnosis: Using the Discharge Diagnosis ICD Codes found in the Primary Diagnosis to determine if a patient has COPD
* Validated against Spirometry results (for patient with a spirometry reading):

Spirometry reading taken from anytime point before. Patient should have Post FEV1/FVC ratio of \< 0.7 in any one of the spirometry readings. If Post FEV1/FVC is not available, we will check if patients have a Pre FEV1/FVC value, and will also include patients with Pre FEV1/FVC ratio of \< 0.7 in any one of the spirometry readings.

Exclusion Criteria:

* Admission diagnosis due to causes other than COPD

Conditions2

COPDCOPD Exacerbation

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.